SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-023201
Filing Date
2024-03-18
Accepted
2024-03-18 07:27:54
Documents
15
Period of Report
2024-03-14
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0201977-8k_biomx.htm   iXBRL 8-K 51977
2 FORM OF WARRANT ea020197701ex4-1_biomx.htm EX-4.1 95748
  Complete submission text file 0001213900-24-023201.txt   399586

Data Files

Seq Description Document Type Size
3 XBRL DEFINITION FILE phge-20240314_def.xml EX-101.DEF 26852
4 XBRL LABEL FILE phge-20240314_lab.xml EX-101.LAB 37202
5 XBRL PRESENTATION FILE phge-20240314_pre.xml EX-101.PRE 25476
6 XBRL SCHEMA FILE phge-20240314.xsd EX-101.SCH 3919
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0201977-8k_biomx_htm.xml XML 6214
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 24756920
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)